Dedicated Blood Culture Diagnostics Cartridge Set for CE-IVD Marketing Release

An application cartridge for the dedicated identification of pathogens in blood cultures is set for CE-IVD market release.

The Curetis N.V. (Holzgerlingen, Germany) Unyvero BCU Blood Culture Application Cartridge covers a broad range of diagnostic targets. These include 87 of the clinically most relevant pathogenic microorganisms, among them Gram positive and Gram negative bacteria, several fungi and atypical pathogens, as well as 16 related antibiotic resistance markers. The cartridge was introduced at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam (The Netherlands), April 8-12, 2016.

While the blood culture cartridge will be available as a consumable for Curetis’ Unyvero System, it is also compatible with the two most common systems and bottle types in the industry—Becton Dickinson (Franklin Lakes, NJ, USA) and bioMérieux (Marcy-l'Étoile, France)—as well as with other blood culture systems and bottles such as those produced by the Thermo Fisher Scientific (Milford, MA, USA) subsidiaries Oxoid and VersaTREK.

The Blood Culture Application Cartridge is the third Application Cartridge made for the Unyvero System. It follows the P55 Pneumonia Application launched in 2015 and the ITI Application for implant and tissue infections launched in 2014.

“We are excited to start marketing the third Application Cartridge for our Unyvero Platform,” said Dr. Achim Plum, chief commercial officer at Curetis. “With over 100 diagnostic targets covered by the Unyvero BCU cartridge, we believe to have the broadest available panel for suspected blood stream infections that can be used with a wide range of routine blood culture systems. The new Unyvero application will provide physicians with timely, comprehensive and actionable information in situations where every hour counts for the patient.”

Related Links:
Curetis N.V. 
Becton Dickinson
bioMérieux